{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:24Z","timestamp":1786118724565,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/01.inf.0000258616.12752.51","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T03:46:47Z","timestamp":1174448807000},"page":"329-333","source":"Crossref","is-referenced-by-count":4,"title":["Perinatal Hepatitis B Transmission and Vaccination Timing in a Managed Care Cohort"],"prefix":"10.1097","volume":"26","author":[{"given":"Soju","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Begier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Schech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Venus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Shatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Miles","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"RR-13","key":"R1-12-20210202","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"40","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"R2-12-20210202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1542\/peds.107.5.1147","article-title":"An assessment of thimerosal use in childhood vaccines.","volume":"107","author":"Ball","year":"2001","journal-title":"Pediatrics"},{"key":"R3-12-20210202","first-page":"563","article-title":"Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-12-20210202","first-page":"780","article-title":"Availability of hepatitis B vaccine that does not contain thimerosal as a preservative.","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-12-20210202","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1542\/peds.2004-2057","article-title":"Assessment of perinatal hepatitis B and rubella prevention in New Hampshire delivery hospitals.","volume":"115","author":"Bascom","year":"2005","journal-title":"Pediatrics"},{"key":"R6-12-20210202","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.291.19.2351","article-title":"Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.","volume":"291","author":"Luman","year":"2004","journal-title":"JAMA"},{"issue":"6,","key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1542\/peds.111.6.e645","article-title":"Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.","volume":"111","author":"Biroscak","year":"2003","journal-title":"Pediatrics"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00006454-200404000-00007","article-title":"Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.","volume":"23","author":"Thomas","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpedi.155.8.915","article-title":"Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations.","volume":"155","author":"Clark","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1542\/peds.107.4.755","article-title":"Impact of the Joint Statement by the American Academy of Pediatrics\/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.","volume":"107","author":"Hurie","year":"2001","journal-title":"Pediatrics"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.285.14.1874","article-title":"Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine.","volume":"285","author":"Oram","year":"2001","journal-title":"JAMA"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1067\/mpd.2001.112896","article-title":"Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.","volume":"138","author":"Brayden","year":"2001","journal-title":"J Pediatr"},{"key":"R13-12-20210202","first-page":"94","article-title":"Impact of the 1999 AAP\/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R14-12-20210202","first-page":"295","article-title":"Pharmacoepidemiology. 3rd ed.","author":"Shatin","year":"2000"},{"key":"R15-12-20210202","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1592\/phco.20.19.1423.34854","article-title":"Tramadol and seizures: a surveillance study in a managed care population.","volume":"20","author":"Gardner","year":"2000","journal-title":"Pharmacotherapy"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200104000-00008","article-title":"Population-based study of rotavirus vaccination and intussusception.","volume":"20","author":"Kramarz","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R17-12-20210202","first-page":"250","article-title":"Population-based hepatitis C surveillance and treatment in a national managed care organization.","volume":"10","author":"Shatin","year":"2004","journal-title":"Am J Manag Care"},{"key":"R18-12-20210202","first-page":"12","article-title":"Recommended childhood immunization schedule\u2014United States, 1999.","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19-12-20210202","first-page":"35","article-title":"Recommended childhood immunization schedule-United States, 2000.","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2105\/AJPH.2004.046284","article-title":"Timeliness of childhood immunizations: a state-specific analysis.","volume":"95","author":"Luman","year":"2005","journal-title":"Am J Public Health"},{"key":"R21-12-20210202","article-title":"Hepatitis Surveillance Report No. 59.","year":"2004"},{"key":"R22-12-20210202","first-page":"311","article-title":"Epidemiologic Notes and Reports Maternal Hepatitis B Screening Practices\u2014California, Connecticut, Kansas, and United States, 1992\u20131993.","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-2","key":"R23-12-20210202","first-page":"1","article-title":"Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP).","volume":"39","year":"1990","journal-title":"MMWR Recomm Rep"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2105\/AJPH.89.1.19","article-title":"Assessing prenatal hepatitis B screening in Illinois with an inexpensive study design adaptable to other jurisdictions.","volume":"89","author":"Barr","year":"1999","journal-title":"Am J Public Health"},{"key":"R25-12-20210202","first-page":"1","article-title":"Summary of notifiable diseases\u2014United States, 2003.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.inf.0000258616.12752.51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:37:09Z","timestamp":1786034229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200704000-00012"}},"subtitle":["Assessment of the Temporary Delay in Newborn Hepatitis B Vaccination Due to Thimerosal Content"],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000258616.12752.51","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}